Juan Manuel Duarte Rojas

Dr. Juan Manuel Duarte Rojas

Basic Biomedical Sciences, University of Antioquia, Medellín, Antioquia, Colombia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
JRJuan Manuel Duarte Rojas
Juan Manuel Duarte Rojas
LRLuz Marina Restrepo
Luz Marina Restrepo
SESergio Estrada
Sergio Estrada
As cell culture supplements, human platelet lysate (PL) and human platelet lysate serum (PLS) are alternatives to fetal bovine serum (FBS) due to FBS-related issues such as ethical concerns, variability between batches, and the possible introduction of xenogenic contaminants. This study compared the composition and efficacy of PL, PLS, and FBS as supplements in the culture and cryopreservation of human dermal fibroblasts, Wharton’s jelly-derived mesenchymal stem cells (WJ-MCS), and adipose tissue (AdMSC). Biochemical components, some growth factors, and cytokines present in each of them were analyzed; in addition, the cells were cultured in media supplemented with 5% PL, 5% PLS, and 10% FBS and exposed to different freezing and thawing solutions with the supplements under study. Biochemical parameters were found to be similar in PL and PLS compared to FBS, with some differences in fibrinogen and calcium concentration. Growth factors and cytokines were higher in PL and PLS compared to FBS. Cell proliferation and morphology showed no significant differences between the three culture media. Regarding the cryopreservation and thawing of cells, better results were obtained with PLS and FBS. In conclusion, PL and PLS are an excellent choice to replace the standard supplement of animal origin (FBS) in the media used for the culture and cryopreservation of fibroblasts, WJ-MSC, and AdMSC.

19 July 2023 in Research Square
Verified
Preprint
Open access
PDF file
JRJuan Manuel Duarte Rojas
Juan Manuel Duarte Rojas
LMLuz Marina Restrepo Munera
Luz Marina Restrepo Munera
SMSergio Estrada Mira
Sergio Estrada Mira
Human platelet lysate (PL) and human platelet lysate serum (PLS) are alternatives to fetal bovine serum (FBS) due to their ethical concerns, variability between batches, and their possible introduction of xenogenic contaminants. This study compared the composition and efficacy of PL, PLS and FBS as supplements in the culture and cryopreservation of human dermal fibroblasts, Wharton’s jelly derived mesenchymal stem cells (WJ-MCS), and adipose tissue (AdMSC). Biochemical components, some growth factors and cytokines present in each of them were analyzed, in addition, the cells were cultured in media supplemented with 5% PL, 5% PLS and 10% FBS, and exposed to different freezing and thawing solutions with the supplements under study. Biochemical parameters were found to be similar in PL and PLS compared to FBS, with some differences in fibrinogen and calcium concentration. Growth factors and cytokines were higher in PL and PLS compared to FBS. Cell proliferation and morphology showed no significant differences between the three-culture media. Regarding the cryopreservation and thawing of cells, better results were obtained with PLS and FBS. In conclusion, PL and PLS are an excellent choice to replace the standard supplement of animal origin (FBS) in the media used for the culture and cryopreservation of fibroblasts, WJ-MSC and AdMSC.

13 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
JRJuan Manuel Duarte Rojas
Juan Manuel Duarte Rojas
LRLuz Marina Restrepo
Luz Marina Restrepo
SESergio Estrada
Sergio Estrada
Background/Objectives: Endothelial cell (EC) culture relies on specialized and commercial media with distinct growth supplement compositions. These media are expensive and must be imported, increasing the time to effective use. Human platelet lysate (PL) and platelet lysate serum (PLS) supplemented media are emerging alternatives to commercial media. Methods: Umbilical cords were collected, and human umbilical vein endothelial cells (HUVEC) were isolated and cultured using different media formulations, using Endothelial Cell Growth, Promocell® (ECGM-Promocell®) commercial medium, and media supplemented with PL and PLS. Results: A mixed medium combining DMEM-F12 + PLS and ECGM-Promocell® maintained EC viability, adhesion, and proliferation. Introducing a PL-derived protein substrate enhanced cell adhesion and proliferation by simulating an extracellular matrix. Flow cytometry revealed positive CD31, CD144, and CD146 markers in cells cultured with ECGM-Promocell® and the mixed medium, with or without the PL-protein substrate. Conclusions: These findings suggest that the mixed medium, especially with the PL protein substrate, offers a cost-effective and efficient approach for EC culture and proliferation, holding promise for research and therapeutic applications.

14 September 2023 in Research Square
Verified
Preprint
Open access
PDF file
JRJuan Manuel Duarte Rojas
Juan Manuel Duarte Rojas
LMLuz Marina Restrepo Múnera
Luz Marina Restrepo Múnera
SMSergio Estrada Mira
Sergio Estrada Mira
Endothelial cell (EC) culture requires specialized and commercial culture media that differ fundamentally in the composition of growth supplements. These media are expensive and must be imported, increasing the time to effective use. Human platelet lysate (PL) and platelet lysate serum (PLS) media are emerging alternatives to commercial media. This study evaluated the performance and behavior of human umbilical vein endothelial cells (HUVEC) using the commercial medium ECGM-Promocell® and media supplemented with PL and PLS. After obtaining informed consent, umbilical cords were collected and HUVEC were isolated. The performance of HUVECs was compared between ECGM-Promocell® commercial medium and media developed from PL and PLS. A PL-derived protein substrate was introduced to pre-treat and form a thin layer on culture plates. The cells were characterized by flow cytometry using the markers CD31, CD144, CD146, CD34, and HLA-DR. A mixed culture medium was obtained from the combination of PLS and ECGM-Promocell® commercial medium, which was able to maintain the viability, adhesion, and proliferation of ECs. At the same time, a protein substrate was implemented using PL, which was added to the surface of the culture plates, being able to simulate an extracellular matrix, facilitating enhanced endothelial cell adhesion, proliferation, and yield. Cells cultured with ECGM-Promocell® and the mixed medium, with and without the PL protein substrate, expressed the surface markers CD31, CD144, and CD146, and were negative for CD34 and HLA-DR markers. The mixed medium together with the PL protein substrate represents excellent alternatives for the culture, maintenance, and proliferation of endothelial cells; being a promising and profitable strategy for the research and production of these cells for therapeutic and research purposes.